Healthcare & Life Sciences
Hospitals, payers, research institutions, and life-science companies share a common pressure: every byte of patient or trial data has a regulatory provenance. Quartz makes that provenance routine to demonstrate.
Regulatory context
The platform supports the access, audit, and integrity controls your privacy office is asked about in every assessment and OCR investigation.
Access management (§164.308(a)(4)), audit controls (§164.312(b)), and integrity (§164.312(c)) are mapped to platform features by default.
Common controls for access management, monitoring, and continuous risk evaluation map to platform configuration with minimal interpretation.
Electronic records and electronic signatures: the audit chain provides record integrity; signed actions provide attribution.
Audit trails and access records for systems supporting regulated study activities, including good clinical and good manufacturing practice scope.
Article 32 technical and organisational measures: continuous verification and signed audit history are evidence the controller can produce.
HIPAA implementation guidance from NIST: the platform addresses the access, audit, and authentication families described therein.
Where it lands first
Time-bound, role-aware access to EHR modules with continuous posture checks. Sessions adapt automatically when device hygiene drifts.
Access boundaries scoped to a study or sponsor, with the audit chain serving as the record requested during inspection.
Strong second-factor enrolment, BYOD-grade posture checks, and per-session policy without standing access.
Per-engagement invitations and per-resource scope for support vendors, with the access trail surviving the engagement.